InnerPulse: Bringing the Interventional Revolution to CRM
Executive Summary
By employing catheter-based technology, a rare cardiac rhythm management start-up is looking to enable more physicians to treat arrhythmias to increase the patient pool and grow the overall electrophysiology device market.
You may also be interested in...
Welsh Carson Taps Into Spinal Market with K2M Buy
Welsh, Carson, Anderson & Stowe, a long time investor in health care services companies, signaled its intent to invest more deeply in the device sector with the acquisition of a majority position in spinal company K2M Inc.
Welsh Carson Taps Into Spinal Market with K2M Buy
Welsh, Carson, Anderson & Stowe, a long time investor in health care services companies, signaled its intent to invest more deeply in the device sector with the acquisition of a majority position in spinal company K2M Inc.
TransEnterix: Managing Revolutions in Surgery
Minimally invasive surgery, performed through a number of ports to create access and enable visualization, manipulation, and dissection, promised to revolutionize surgical techniques two decades ago, but ultimately fell short of changing the way surgeons perform the majority of surgical cases. Now, the next generation in minimally invasive surgery sees single-port surgeries and natural orifice transluminal endoscopic surgeries (NOTES) gaining momentum. TransEnterix aims to operate in both cases, with a novel approach that not only allows surgeons greater dexterity in performing complex procedures, but also enables them to do surgical cases through a single access port, using the body's umbilicus